Investigation of radiosensitivity gene signatures in cancer cell lines

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hall, John S ^a   Iype, Rohan ^a   Senra, Joana ^a,b   Taylor, Janet ^a,c   Armenoult, Lucile ^a   Oguejiofor, Kenneth ^a   Li, Yaoyong ^c   Stratford, Ian ^a   Stern, Peter L ^c   O'Connor, Mark J ^d   Miller, Crispin J ^c   West, Catharine M L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P63; RNA;

ARTICLE; CANCER CELL LINE; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; EXON; GENE IDENTIFICATION; GENE SIGNATURE; GENOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IRRADIATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RADIOSENSITIVITY; RNA EXTRACTION; TUMOR GENE; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; ORGAN SPECIFICITY; PROTEOME; PROTEOMICS; RADIATION TOLERANCE; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; UTERINE CERVICAL NEOPLASMS;

EID: 84899644661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086329     Document Type: Article

References (42)

1. Williams MV, Drinkwater KJ (2009) Radiotherapy in England in 2007: modelled demand and audited activity. Clin Oncol (R Coll Radiol) 21: 575-590.
2. Bristow RG, Hill RP (1990) Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations. Int J Radiat Oncol Biol Phys 18: 331-345. (Pubitemid 20097528)
3. West CM, Davidson SE, Roberts SA, Hunter RD (1997) The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 76: 1184-1190. (Pubitemid 27448015)
4. Bjork-Eriksson T, West C, Karlsson E, Mercke C (2000) Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int J Radiat Oncol Biol Phys 46: 13-19. (Pubitemid 30021473)
5. West CM, Hendry JH (1992) Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. BJR Suppl 24: 146-152.
6. Otomo T, Hishii M, Arai H, Sato K, Sasai K (2004) Microarray analysis of temporal gene responses to ionizing radiation in two glioblastoma cell lines: upregulation of DNA repair genes. J Radiat Res 45: 53-60. (Pubitemid 38698649)
7. Chung YM, Kim BG, Park CS, Huh SJ, Kim J, et al. (2005) Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 117: 194-201. (Pubitemid 41377438)
8. Tewari D, Monk BJ, Al-Ghazi MS, Parker R, Heck JD, et al. (2005) Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study. Gynecol Oncol 99: 84-91. (Pubitemid 41354587)
9. Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, et al. (2009) DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther 8: 713-724.
10. Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, et al. (2008) Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res 68: 415-424. (Pubitemid 351380067)
11. Eschrich S, Fulp WJ, Pawitan Y, Foekens JA, Smid M, et al. (2012) Validation of a Radiosensitivity Molecular Signature in Breast Cancer. Clin Cancer Res 18: 5134-5143.
12. Eschrich S, Zhang H, Zhao H, Boulware D, Lee JH, et al. (2009) Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiat Oncol Biol Phys 75: 497-505.
13. Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, et al. (2009) A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys 75: 489-496.
14. Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, et al. (2005) Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 65: 7169-7176. (Pubitemid 41161247)
15. Eschrich SA, Fulp WJ, Pawitan Y, Foekens JA, Smid M, et al. (2012) Validation of a radiosensitivity molecular signature in breast cancer. Clin Cancer Res 18: 5134-5143.
16. Kim HS, Kim SC, Kim SJ, Park CH, Jeung HC, et al. (2012) Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells. BMC genomics 13: 348.
17. Fertil B, Malaise EP (1985) Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11: 1699-1707. (Pubitemid 15233633)
18. Barbieri CE, Tang LJ, Brown KA, Pietenpol JA (2006) Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 66: 7589-7597. (Pubitemid 44289215)
19. Brady CS, Bartholomew JS, Burt DJ, Duggan-Keen MF, Glenville S, et al. (2000) Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens 55: 401-411. (Pubitemid 30316150)
20. Marples B, Longhurst D, Eastham AM, West CM (1998) The ratio of initial/residual DNA damage predicts intrinsic radiosensitivity in seven cervix carcinoma cell lines. Br J Cancer 77: 1108-1114. (Pubitemid 28116282)
21. Hall JS, Leong HS, Armenoult LS, Newton GE, Valentine HR, et al. (2011) Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. Br J Cancer 104: 971-981.
22. Hall JS, Iype R, Armenoult LS, Taylor J, Miller CJ, et al. (2013) Poor Prognosis Associated With Human Papillomavirus alpha7 Genotypes in Cervical Carcinoma Cannot Be Explained by Intrinsic Radiosensitivity. Int J Radiat Oncol Biol Phys 85: e223-229.
23. Pawlak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, et al. (2002) Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2: 383-393. (Pubitemid 34429356)
24. Begg AC, Stewart FA, Vens C (2011) Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 11: 239-253.
25. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
26. Yates T, Okoniewski MJ, Miller CJ (2008) X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis. Nucleic Acids Res 36: D780-786. (Pubitemid 351149823)
27. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
28. Roberts SA (1990) DRFIT: a program for fitting radiation survival models. Int J Radiat Biol 57: 1243-1246.
29. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
30. Banath JP, Macphail SH, Olive PL (2004) Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 64: 7144-7149. (Pubitemid 39331029)
31. Pedersen N, Mortensen S, Sorensen SB, Pedersen MW, Rieneck K, et al. (2003) Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res 63: 1943-1953. (Pubitemid 36460862)
32. Senoo M, Pinto F, Crum CP, McKeon F (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129: 523-536. (Pubitemid 46660965)
33. Crook T, Wrede D, Vousden KH (1991) p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6: 873-875. (Pubitemid 21924163)
34. Dobbin E, Corrigan PM, Walsh CP, Welham MJ, Freeburn RW, et al. (2008) Tel/PDGFRbeta inhibits self-renewal and directs myelomonocytic differentiation of ES cells. Leuk Res 32: 1554-1564.
35. Dobbin KK, Zhao Y, Simon RM (2008) How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res 14: 108-114. (Pubitemid 351377984)
36. Toustrup K, Sorensen BS, Alsner J, Overgaard J (2012) Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Semin Radiat Oncol 22: 119-127.
37. Kim MK, Kim TJ, Sung CO, Choi CH, Lee JW, et al. (2010) High expression of mTOR is associated with radiation resistance in cervical cancer. J Gynecol Oncol 21: 181-185.
38. Hampson L, El Hady ES, Moore JV, Kitchener H, Hampson IN (2001) The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma. FASEB J 15: 1445-1447.
39. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056.
40. Moeller BJ, Yordy JS, Williams MD, Giri U, Raju U, et al. (2011) DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin Cancer Res 17: 2035-2043.
41. Choudhury A, Nelson LD, Teo MT, Chilka S, Bhattarai S, et al. (2010) MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. Cancer Res 70: 7017-7026.
42. Pavon MA, Parreno M, Leon X, Sancho FJ, Cespedes MV, et al. (2008) Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Int J Cancer 123: 1068-1079.